Why Turkey could still trouble global markets
It may seem churlish to worry, given the enthusiastic response the markets are giving to news of the Phase III Covid-19 vaccine trial by Pfizer and BioNTech, but investors need to keep an eye on Turkey once more.The Turkish lira is...
12 November 2020
